Globus Medical Price to Free Cash Flow Ratio 2011-2025 | GMED
Historical price to free cash flow ratio values for Globus Medical (GMED) since 2011.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Globus Medical Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-11-14 | 84.45 | 19.84 | |
| 2025-09-30 | 57.27 | $4.26 | 13.45 |
| 2025-06-30 | 59.02 | $3.84 | 15.39 |
| 2025-03-31 | 73.20 | $3.77 | 19.40 |
| 2024-12-31 | 82.71 | $2.94 | 28.14 |
| 2024-09-30 | 71.54 | $2.25 | 31.76 |
| 2024-06-30 | 68.49 | $1.27 | 53.79 |
| 2024-03-31 | 53.64 | $1.25 | 42.84 |
| 2023-12-31 | 53.29 | $1.44 | 36.97 |
| 2023-09-30 | 49.65 | $1.16 | 42.74 |
| 2023-06-30 | 59.54 | $1.18 | 50.26 |
| 2023-03-31 | 56.64 | $1.15 | 49.47 |
| 2022-12-31 | 74.27 | $1.02 | 73.01 |
| 2022-09-30 | 59.57 | $1.16 | 51.23 |
| 2022-06-30 | 56.14 | $1.51 | 37.13 |
| 2022-03-31 | 73.78 | $1.87 | 39.51 |
| 2021-12-31 | 72.20 | $2.12 | 34.10 |
| 2021-09-30 | 76.62 | $2.19 | 35.06 |
| 2021-06-30 | 77.53 | $1.97 | 39.31 |
| 2021-03-31 | 61.67 | $1.63 | 37.83 |
| 2020-12-31 | 65.22 | $1.34 | 48.73 |
| 2020-09-30 | 49.52 | $1.07 | 46.50 |
| 2020-06-30 | 47.71 | $1.15 | 41.64 |
| 2020-03-31 | 42.53 | $1.08 | 39.42 |
| 2019-12-31 | 58.88 | $0.99 | 59.33 |
| 2019-09-30 | 51.12 | $0.90 | 57.02 |
| 2019-06-30 | 42.30 | $0.83 | 50.70 |
| 2019-03-31 | 49.41 | $0.96 | 51.21 |
| 2018-12-31 | 43.28 | $1.25 | 34.54 |
| 2018-09-30 | 56.76 | $1.29 | 43.96 |
| 2018-06-30 | 50.46 | $1.15 | 43.89 |
| 2018-03-31 | 49.82 | $1.07 | 46.71 |
| 2017-12-31 | 41.10 | $1.10 | 37.34 |
| 2017-09-30 | 29.72 | $0.91 | 32.78 |
| 2017-06-30 | 33.15 | $1.06 | 31.40 |
| 2017-03-31 | 29.62 | $1.06 | 27.93 |
| 2016-12-31 | 24.81 | $1.11 | 22.38 |
| 2016-09-30 | 22.57 | $1.32 | 17.16 |
| 2016-06-30 | 23.83 | $1.13 | 21.00 |
| 2016-03-31 | 23.75 | $0.96 | 24.84 |
| 2015-12-31 | 27.82 | $0.76 | 36.49 |
| 2015-09-30 | 20.66 | $0.35 | 58.26 |
| 2015-06-30 | 25.67 | $0.50 | 51.43 |
| 2015-03-31 | 25.24 | $0.61 | 41.12 |
| 2014-12-31 | 23.77 | $0.57 | 41.69 |
| 2014-09-30 | 19.67 | $0.94 | 20.98 |
| 2014-06-30 | 23.92 | $0.90 | 26.69 |
| 2014-03-31 | 26.59 | $0.86 | 30.90 |
| 2013-12-31 | 20.18 | $0.74 | 27.24 |
| 2013-09-30 | 17.46 | $0.64 | 27.47 |
| 2013-06-30 | 16.86 | $0.71 | 23.60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.303B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.426B | 25.83 |
| Intuitive Surgical (ISRG) | United States | $196.986B | 77.07 |
| IDEXX Laboratories (IDXX) | United States | $55.092B | 54.71 |
| Edwards Lifesciences (EW) | United States | $50.080B | 33.58 |
| Alcon (ALC) | Switzerland | $38.300B | 25.88 |
| IQVIA Holdings (IQV) | United States | $37.570B | 20.95 |
| Mettler-Toledo (MTD) | United States | $28.663B | 33.53 |
| STERIS (STE) | Ireland | $25.362B | 26.18 |
| DexCom (DXCM) | United States | $22.644B | 31.22 |
| Waters (WAT) | United States | $22.587B | 29.87 |
| Hologic (HOLX) | United States | $16.492B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.115B | 0.00 |
| Penumbra (PEN) | United States | $10.968B | 77.15 |
| Masimo (MASI) | United States | $8.117B | 26.01 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.171B | 0.00 |
| Teleflex (TFX) | United States | $4.729B | 7.54 |
| TransMedics (TMDX) | United States | $3.930B | 46.56 |
| Veracyte (VCYT) | United States | $3.111B | 35.45 |
| LivaNova (LIVN) | United Kingdom | $3.023B | 16.33 |
| Alphatec Holdings (ATEC) | United States | $2.932B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.435B | 11.43 |
| Artivion (AORT) | United States | $2.165B | 99.35 |
| Nihon Kohden (NHNKY) | Japan | $2.021B | 17.64 |
| Elekta AB (EKTAY) | Sweden | $1.737B | 16.83 |
| PROCEPT BioRobotics (PRCT) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.262B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.197B | 0.00 |
| AxoGen (AXGN) | United States | $1.086B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.12 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.976B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.915B | 4.96 |
| SiBone (SIBN) | United States | $0.756B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.529B | 30.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.55 |
| AngioDynamics (ANGO) | United States | $0.499B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.486B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 11.27 |
| RxSight (RXST) | United States | $0.400B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.376B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.331B | 2.49 |
| Delcath Systems (DCTH) | United States | $0.315B | 52.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.315B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| InspireMD (NSPR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.24 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |